respiratori
gene
therapi
consid
treatment
broad
rang
pulmonari
disord
howev
respiratori
secret
form
import
barrier
toward
pulmonari
deliveri
therapeut
nucleic
acid
review
start
brief
descript
biophys
properti
respiratori
mucu
alveolar
fluid
must
allow
reader
gain
insight
mechan
respiratori
secret
may
imped
gene
transfer
effici
nucleic
acid
contain
nanoparticl
nan
subsequ
summar
effort
done
understand
barrier
properti
respiratori
mucu
alveolar
fluid
toward
respiratori
deliveri
therapeut
nucleic
acid
final
new
current
strategi
overcom
inhibitori
effect
respiratori
secret
discuss
respiratori
gene
therapi
consid
treatment
varieti
lung
diseas
like
cystic
fibrosi
cf
asthma
emphysema
lung
cancer
antitrypsin
defici
surfact
proteinb
spb
defici
addit
dna
vaccin
via
respiratori
tract
may
also
interest
certain
infecti
diseas
recent
deliveri
sirna
contain
nanoparticl
lung
also
gain
much
attent
treatment
lung
infect
caus
eg
sar
sever
acut
respiratori
syndrom
avian
influenza
virus
howev
known
lung
infect
may
cf
patient
lead
product
purul
respiratori
secret
alter
secret
may
drastic
lower
number
sirna
molecul
reach
target
cell
lung
depend
respiratori
diseas
therapeut
goal
target
cell
lung
vari
epitheli
cell
alveolar
cell
macrophag
respiratori
stem
cell
endotheli
cell
cell
type
except
latter
two
directli
access
via
inhal
instil
nucleic
acid
contain
nanoparticl
nan
deliveri
rout
advantag
exclus
target
lung
therebi
prevent
nan
endup
nontarget
tissu
addit
play
around
diamet
aerosol
droplet
possibl
direct
disposit
nan
tracheobronchi
droplet
diamet
alveolar
region
droplet
diamet
nevertheless
system
administr
still
best
deliveri
rout
nan
need
transfect
endotheli
cell
capillari
suppli
blood
eg
lung
tumor
respiratori
stem
cell
interest
target
genet
diseas
like
cf
howev
nan
reach
respiratori
stem
cell
open
tight
junction
epitheli
cell
alveolar
cell
therapeut
effici
nucleic
acid
deliveri
lung
depend
capac
nan
overcom
differ
barrier
toward
respiratori
gene
therapi
effect
nan
withstand
shear
forc
nebul
overcom
mucu
layer
cover
conduct
airway
liquid
layer
alveoli
overcom
antibodi
macrophag
target
cell
enter
target
cell
escap
endosom
addit
therapeut
nucleic
acid
gene
nan
gene
also
enter
nucleu
review
focu
extracellular
barrier
encount
pulmonari
deliv
nan
way
epitheli
cell
pneumocyt
lung
macrophag
goal
review
discu
barrier
mention
summar
outcom
vivo
experi
clinic
trial
field
respiratori
gene
therapi
latter
cover
recent
review
allow
reader
gain
insight
mechan
extracellular
fluid
lung
may
affect
perform
nan
start
review
brief
introduct
biochem
physic
properti
especi
respiratori
mucu
alveolar
fluid
part
follow
overview
discuss
scientif
paper
deal
behavior
nan
differ
extracellular
secret
present
respiratori
tract
effort
respiratori
gene
therapi
focus
cf
gene
therapi
therefor
special
attent
given
extracellular
barrier
cf
gene
therapi
cf
common
lethal
autosomalrecess
disord
caucasian
affect
approxim
newborn
character
presenc
tenaci
mucu
lung
intestin
vagina
howev
fifteen
year
preclin
clinic
research
use
viral
nonvir
nan
reveal
deliveri
cftr
gene
lung
epithelium
cf
patient
difficult
task
extracellular
barrier
play
import
role
failur
cf
gene
therapi
last
part
review
discuss
strategi
evalu
overcom
differ
extracellular
barrier
respiratori
gene
therapi
addit
also
suggest
new
strategi
may
enhanc
success
respiratori
gene
therapi
air
daili
inhal
contain
besid
ga
also
dust
toxic
substanc
pathogen
therefor
lung
develop
ingeni
mechan
remov
andor
neutral
alien
materi
one
import
defens
mechan
inhal
materi
respiratori
mucu
line
respiratori
epithelium
nose
termin
bronchiol
mucu
layer
lay
tip
cilia
bath
periciliari
fluid
layer
inhal
materi
captur
blanket
mucu
togeth
mucu
continu
transport
cilia
esophagu
physic
properti
respiratori
mucu
determin
effici
mucociliari
clearanc
mechan
inde
lung
diseas
character
tenaci
mucu
mucociliari
clearanc
impair
elimin
mucu
occur
via
cough
thick
mucu
layer
depend
locat
airway
presenc
patholog
condit
although
difficult
determin
report
nonpatholog
condit
thick
vari
trachea
bronchi
howev
report
claim
thick
mucu
layer
vari
cf
respiratori
diseas
mucu
layer
much
thicker
respiratori
mucu
mainli
compos
threedimension
network
crosslink
mucin
chain
give
mucu
viscoelast
properti
globlet
cell
submucos
gland
produc
mucin
mucin
built
subunit
bound
togeth
headtotail
intramolecular
disulfid
bridg
subunit
length
nm
consist
highli
glycosyl
protein
backbon
nonglycosyl
end
molecular
weight
mucin
vari
mda
mucin
neg
charg
due
presenc
nacetylneuram
acid
also
call
sialic
acid
sulphat
monosaccharid
sugar
chain
latter
contain
sugar
monom
coval
link
oglycosid
bound
nacetylgalactosamin
serin
threonin
residu
import
realiz
epitheli
layer
secret
characterist
mucin
therefor
biophys
characterist
mucu
depend
locat
bodi
respiratori
tract
two
type
mucin
mainli
express
addit
found
glycosyl
pattern
respiratori
mucin
alter
cf
patient
concentr
differ
constitu
physic
properti
normal
respiratori
mucu
studi
detail
difficult
collect
normal
lung
mucu
therefor
fig
schemat
represent
human
respiratori
mucin
carbohydr
side
chain
mucin
consist
subunit
attach
disulfid
bond
subunit
highli
glycosyl
protein
nonglycosyl
end
depict
carbohydr
chain
illustr
ala
gli
pro
thr
ga
gan
gn
na
correspond
respect
alanin
glycin
prolin
threonin
galactos
nacetylgalactosamin
nacetylglucosamin
nacetylneuramin
acid
adapt
ref
mani
studi
perform
mucu
obtain
patient
mucu
hypersecret
eg
patient
cf
chronic
obstruct
pulmonari
diseas
copd
nevertheless
nonpatholog
mucu
mucin
concentr
gl
cf
sputum
ie
respiratori
mucu
expector
cf
patient
slightli
lower
mucin
concentr
found
tabl
howev
higher
mucin
concentr
gl
found
cf
patient
produc
tenaci
sputum
tabl
give
overview
concentr
abund
compound
cf
sputum
water
content
sputum
cf
patient
mucu
healthi
individu
contain
water
besid
mucin
water
mucu
also
contain
protein
lipid
proteoglycan
electrolyt
major
protein
respiratori
mucu
albumin
proteas
antiproteas
immunoglobulin
lysozym
lactoferrin
respiratori
secret
patient
cystic
fibrosi
respiratori
infect
also
contain
huge
amount
dna
actin
tabl
biopolym
deriv
neutrophil
epitheli
cell
pathogen
die
subsequ
releas
intracellular
content
mucu
dna
actin
like
mucin
high
molecular
weight
crosslink
therebi
form
dna
actin
gel
fig
b
properti
dna
actin
drastic
increas
viscoelast
cf
mucu
addit
mucin
dna
actin
chain
also
interact
physic
entangl
chemic
hydrogen
bond
electrostat
hydrophob
interact
interestingli
tight
bind
respiratori
mucin
lipid
report
interact
may
make
mucin
chain
hydrophob
interact
mucu
constitu
make
cf
mucu
one
complex
biopolym
network
alveolar
epithelium
cover
thin
continu
layer
pulmonari
surfact
compris
phospholipid
specif
surfactantassoci
protein
synthes
secret
type
ii
alveolar
cell
aqueou
alveolar
subphas
lie
pulmonari
surfact
film
alveolar
epithelium
averag
thick
rang
flat
alveolar
wall
alveolar
corner
major
function
pulmonari
surfact
reduc
surfac
tension
airwat
interfac
termin
airway
therebi
reduc
tendenc
alveoli
collaps
detail
composit
pulmonari
surfact
character
biochem
analysi
bronchoalveolar
lavag
fluid
balf
compos
lipid
protein
although
lipid
ultim
respons
reduct
surfac
tension
inhal
expir
surfactantassoci
protein
suggest
assist
within
process
lipid
phophatidylcholin
pc
abund
pc
zwitterion
dipalmitoylphospatidylcholin
dppc
pc
substanti
contribut
uniqu
properti
pulmonari
surfact
residu
pc
surfact
primarili
consist
molecular
deriv
contain
monoeno
dienoic
fatti
acid
minor
amount
short
chain
polyunsatur
acyl
group
acid
thu
neg
charg
phospholipid
phosphatidylglycerol
pg
phosphatidylinositol
pi
account
total
surfact
phospholipid
low
level
phophatidylserin
ps
also
present
balf
posit
charg
phosphatidylethanolamin
pe
account
total
surfact
phospholipid
addit
neutral
lipid
cholesterol
found
vari
level
pulmonari
surfact
protein
fraction
balf
contain
highli
variabl
amount
serum
protein
total
amount
protein
protein
specif
express
lung
among
four
surfact
protein
surfact
protein
sp
term
spa
b
c
wherea
hydrophil
surfact
protein
spa
spd
play
essenti
role
pulmonari
immun
defens
spb
spc
lower
surfac
tension
facilit
format
stabil
surfact
film
major
protein
found
balf
albumin
transferrin
antitrypsin
immuglobulin
g
togeth
protein
origin
either
plasma
express
lung
tissu
case
protein
may
deriv
plasma
secret
lung
tissu
eg
antitrypsin
total
protein
concentr
roughli
estim
dilut
alf
approxim
mgml
concentr
albumin
predomin
protein
alf
approxim
mgml
final
nucleic
acid
mucin
glycoprotein
massiv
amount
white
blood
cell
found
balf
viscoelast
determin
rotat
rheomet
ar
tainstrument
use
conepl
geometri
twenti
two
cf
sputa
analyz
mean
valu
deviat
shown
balf
also
protect
alveoli
pathogen
inde
inhal
pathogen
becom
opson
spa
spd
immunoglobulin
subsequ
elimin
via
alveolar
macrophag
therefor
alveolar
fluid
repres
critic
immunolog
barrier
overcom
nan
bind
apic
membran
pneumocyt
addit
charg
compound
b
alf
may
also
interact
nan
therebi
chang
surfac
properti
even
disrupt
nan
fatal
interact
discuss
section
three
phenomena
may
prevent
inhal
intratrach
instil
nan
reach
lung
epithelium
first
biopolym
network
build
mucu
may
hinder
diffus
nan
steric
obstruct
bind
nan
second
noncrosslink
ie
free
move
macro
molecul
may
also
bind
surfac
nan
latter
lead
aggreg
nan
imped
capac
move
mesh
biopolym
network
mucu
addit
even
aggreg
occur
report
bind
extracellular
compound
surfac
nan
may
drastic
decreas
gene
transfer
capac
third
mention
mucu
blanket
continu
remov
via
mucociliari
transport
cough
therefor
nan
abl
cross
mucu
layer
clear
respiratori
tract
respiratori
cilia
transport
mucu
rate
mmmin
howev
speed
mucu
clearanc
may
drastic
chang
patholog
situat
like
cystic
fibrosi
therefor
diffus
coeffici
nan
mucu
thick
mucu
layer
rate
mucu
clearanc
determin
whether
nan
reach
epitheli
cell
section
first
focu
transport
nan
nanoparticl
often
use
simpl
model
nan
respiratori
mucu
subsequ
interact
nan
respiratori
mucu
discuss
review
consid
respiratori
mucu
expect
transport
interact
nan
type
mucu
complet
repres
respiratori
mucu
exampl
mobil
nanospher
much
lower
cervic
mucu
cf
copd
mucu
addit
cervic
mucu
anoth
biochem
composit
respiratori
mucu
much
lower
viscos
copd
cf
mucu
inform
mobil
nan
respiratori
mucu
scarc
howev
polystyren
nanoparticl
use
sever
paper
gain
insight
mobil
nanos
drug
carrier
respiratori
mucu
knowledg
three
group
far
studi
mobil
nanos
particl
respiratori
mucu
find
three
group
review
section
group
evalu
first
transport
neg
charg
polystyren
nanospher
cation
lipoplex
ie
complex
nucleic
acid
cation
liposom
sputa
cf
patient
experi
sandwich
thick
layer
cf
sputum
donor
acceptor
side
vertic
diffus
chamber
fig
number
nanospher
lipoplex
transport
min
cf
sputum
layer
low
thin
cf
sputum
layer
place
donor
acceptor
side
use
modifi
snapwel
snapwel
contain
polycarbon
membran
pore
size
modifi
glu
thick
ring
border
ring
fill
cf
sputum
seal
second
polycarbon
membran
final
modifi
snapwel
place
donor
acceptor
side
diffus
experi
start
fill
donor
side
nanoparticl
nan
acceptor
side
buffer
subsequ
transport
nanoparticl
nan
sputum
layer
follow
measur
desir
time
point
concentr
acceptor
side
total
number
particl
present
donor
side
strongli
depend
size
particl
fig
transport
nm
nm
nm
nanospher
equal
size
buffer
layer
respect
higher
cf
sputum
smallest
nanospher
retard
cf
sputum
factor
hypothes
mesh
cf
sputum
must
larg
enough
allow
less
free
passag
nanospher
data
also
indic
small
particl
nm
low
transport
cf
sputum
primarili
due
distanc
ie
thick
sputum
layer
particl
travel
larger
particl
nm
low
transport
cf
sputum
due
latter
phenomenon
well
steric
obstruct
particl
biopolym
network
cf
sputum
fact
largest
nanospher
nm
almost
move
cf
sputum
may
indic
mesh
biopolym
cf
sputum
small
allow
free
passag
nanospher
inde
via
scan
electron
microscopi
found
cf
sputum
contain
mani
small
mesh
nm
mesh
nm
almost
mesh
nm
fig
similar
mesh
size
recent
detect
cf
sputa
via
atom
forc
microscopi
afm
mean
mesh
size
deviat
determin
afm
cf
sputa
nm
nm
nm
although
mesh
size
larger
one
deriv
electron
microscopi
pictur
cf
sputum
still
larg
enough
allow
complet
unhind
passag
nm
nanospher
final
unexpectedli
observ
nanospher
diffus
easili
viscoelast
sputa
fig
explain
hypothes
highli
viscoelast
sputa
higher
amount
entangl
biopolym
enabl
format
heterogen
macropor
network
mesh
contain
limit
number
free
biopolym
viscos
mesh
ie
microviscos
determin
mobil
nanospher
cf
sputa
cours
latter
hold
true
nanospher
small
enough
enter
mesh
sputa
cf
sputa
low
viscoelast
homogen
micropor
network
mani
free
biopolym
mesh
probabl
present
therefor
microviscos
low
viscoelast
sputa
probabl
higher
microviscos
high
viscoelast
sputa
henc
nanoparticl
low
viscoelast
sputum
experi
higher
viscou
drag
viscoelast
sputum
base
hypothesi
degrad
biopolym
network
cf
sputum
mucolyt
drug
may
ideal
strategi
enhanc
transport
nanoparticl
mucu
inde
cleav
biopolym
network
increas
mesh
size
also
viscou
drag
mesh
biopolym
latter
effect
expect
cleav
polym
fragment
releas
mesh
network
perspect
diffus
particl
two
effect
counteract
increas
mesh
size
give
nanoparticl
space
move
sputum
increas
number
free
polym
mesh
slow
effect
mucolyt
cf
sputum
sampl
process
previous
describ
reproduc
ref
bar
principl
multipl
particl
track
mpt
experi
highspe
film
record
particl
particl
size
microscop
resolut
limit
seen
dot
light
gaussian
intens
distribut
howev
suitabl
imag
process
softwar
one
determin
centr
particl
high
accuraci
typic
order
ten
nanomet
determin
posit
particl
frame
mpt
film
trajectori
calcul
individu
particl
shown
color
line
mean
squar
displac
msd
trajectori
use
quantit
analysi
term
mode
motion
free
diffus
direct
transport
etc
correspond
quantit
paramet
diffus
coeffici
veloc
b
trajectori
freediffus
red
confin
green
particl
shown
graph
right
depict
correspond
msd
particl
function
lag
time
interpret
refer
color
figur
legend
reader
refer
web
version
articl
agent
transport
nanoparticl
gene
transfer
capac
nan
discuss
detail
section
group
justin
hane
use
multipl
particl
track
mpt
also
sometim
indic
singl
particl
track
spt
gain
insight
diffus
characterist
individu
nanospher
cf
sputum
mpt
trajectori
ten
nanospher
fluoresc
label
simultan
follow
collect
sequenti
imag
epifluoresc
microscop
equip
fast
sensit
ccd
camera
fig
analysi
imag
local
nanospher
possibl
reconstitut
trajectori
nanospher
trajectori
possibl
calcul
distanc
mean
squar
displac
msd
nanospher
travel
certain
timefram
msd
relat
diffus
coeffici
differ
model
depend
type
motion
work
dawson
et
al
trajectori
neg
charg
polystyren
nanospher
vari
diamet
nm
defin
supplier
monitor
cf
sputum
averag
diffus
coeffici
nm
nanospher
cf
sputum
measur
mpt
lower
buffer
work
sander
et
al
cf
sputum
caus
much
lower
retard
nanospher
howev
import
stress
mpt
reveal
transport
rate
individu
nanospher
one
cf
sputum
sampl
show
broad
distribut
inde
small
fraction
nm
nanospher
show
transport
rate
higher
averag
transport
rate
whole
popul
fastmov
fraction
observ
nm
nanospher
fraction
highli
mobil
nanospher
probabl
measur
work
sander
et
al
exist
fraction
nanospher
rapidli
move
cf
sputum
may
indic
limit
number
consecut
larg
mesh
form
transport
highway
nm
nanospher
therefor
crucial
nan
find
channel
get
lost
narrow
orand
twist
side
road
addit
mpt
also
detect
fluctuat
speed
individu
nanospher
attribut
tempor
cage
nanospher
region
sputum
mesh
size
small
allow
free
diffus
studi
trajectori
individu
nanospher
cf
sputum
group
hane
et
al
also
abl
probe
microviscos
nanospher
encount
cf
sputum
interestingli
encount
microviscos
nm
nanospher
respect
lower
sputum
macroviscos
measur
rheomet
fact
nm
nanospher
sens
higher
appar
viscos
probabl
due
partial
steric
hinder
nanospher
biopolym
network
cf
sputum
suggest
sander
et
al
final
dawson
et
al
also
found
neg
charg
polystyren
nanospher
bound
probabl
via
hydrophob
interact
strongli
biopolym
cf
sputum
neutral
polystyren
nanospher
via
fluoresc
recoveri
photobleach
frap
also
found
small
polystyren
nanospher
nm
measur
via
dynam
light
scatter
becom
immobil
certain
region
within
cf
sputum
furthermor
coat
polystyren
nanospher
polyethylen
glycol
strongli
decreas
bind
biopolym
present
cervic
mucu
bind
interact
mucu
compound
nan
discuss
detail
section
final
group
jani
shute
et
al
use
microboyden
chamber
studi
diffus
nm
neg
charg
polystyren
nanospher
cf
sputum
experi
mix
nanospher
cf
sputum
subsequ
sputum
nanospher
transfer
upper
chamber
diffus
chamber
separ
lower
chamber
fill
buffer
membran
pore
size
h
measur
amount
nanospher
lower
compart
compar
nanospher
mix
buffer
control
cf
sputum
caus
decreas
transport
nonvir
nan
built
cation
lipid
polym
bind
therapeut
dna
rna
electrostat
interact
first
gener
nonvir
nan
also
posit
charg
surfac
addit
import
realiz
also
certain
virus
like
herp
simplex
viru
certain
retrovirus
posit
surfac
charg
consequ
one
expect
viral
nan
base
virus
bind
via
charg
interact
neg
charg
compon
present
mucu
addit
compon
mucu
like
antibodi
may
interact
nan
interact
nan
mucu
compound
may
caus
entrap
nan
mucu
aggreg
nan
due
neutral
surfac
charg
releas
therapeut
dnarna
nonvir
nan
ineffici
cell
bind
nan
due
shield
posit
charg
receptor
bind
ligand
endosom
entrap
nan
effect
strongli
imped
gene
transfer
effici
nan
presenc
mucu
inform
interact
nan
respiratori
mucu
scarc
nevertheless
differ
research
report
neg
charg
well
neutral
polystyren
nanospher
bind
filament
present
cf
sputum
cervic
mucu
indic
neg
nanospher
adher
polym
filament
via
hydrophob
interact
filament
also
neg
charg
addit
shown
cation
herp
simplex
virus
stick
mucin
filament
present
cervic
mucu
data
indic
nan
may
prone
interact
respiratori
cf
mucu
due
lack
report
topic
section
mainli
focu
data
examin
influenc
individu
cf
sputum
compon
dilut
cf
sputum
physicochem
stabil
gene
transfect
activ
cation
dotapdop
lipoplex
incub
lipoplex
increas
amount
albumin
linear
dna
mucin
decreas
revers
surfac
charg
nan
clearli
indic
neg
charg
cf
mucu
compon
bind
cation
nan
moreov
crossov
point
posit
neg
charg
lipoplex
observ
massiv
aggreg
lipoplex
strong
reduct
gene
transfer
effici
latter
probabl
due
decreas
intern
larg
aggreg
interestingli
higher
amount
albumin
linear
dna
creat
anion
shield
around
lipoplex
protect
aggreg
remark
albumin
linear
dna
cover
lipoplex
signific
decreas
gene
transfer
effici
vitro
although
linear
dna
albumin
releas
small
amount
pdna
lipoplex
contrast
bind
mucin
strongli
decreas
gene
transfer
dotapdop
lipoplex
without
caus
larg
aggreg
dissoci
lipoplex
indic
mucin
alter
intra
cellular
step
transfect
process
lipoplex
final
cation
dotapdop
lipoplex
slightli
releas
pdna
incub
dilut
cf
sputa
obtain
patient
respect
moder
sever
lung
infect
contrast
massiv
dissoci
cation
dotapdop
lipoplex
observ
incub
dilut
synthet
sputum
ie
mixtur
albumin
linear
dna
mucin
lung
surfact
known
network
structur
cf
sputum
simul
simpli
mix
cf
sputum
constitu
synthet
sputum
cf
sputum
compon
well
crosslink
thu
avail
fatal
interact
nan
similarli
dilut
cf
sputa
may
liber
cf
sputum
compon
polym
network
would
otherwis
abl
bind
surfac
lipoplex
consequ
observ
dissoci
nan
presenc
cf
sputum
compound
dilut
cf
sputum
may
gener
data
overestim
potenti
disintegr
nan
undilut
cf
sputum
group
alton
et
al
studi
effect
normal
respiratori
mucu
cf
sputum
gene
transfer
capac
lipoplex
polyplex
adenovir
vector
first
paper
cover
cell
cultur
mm
thick
layer
dilut
cf
sputum
least
dilut
sputa
ie
dilut
cultur
medium
caus
reduct
gene
transfer
effici
dcchol
dope
base
lipoplex
adenovir
vector
strikingli
highli
dilut
sputa
ie
also
caus
drastic
reduct
gene
transfer
adenovir
vector
especi
lipoplex
indic
cf
sputum
diffus
barrier
nan
high
dilut
polym
network
sputum
viscos
expect
disrupt
drastic
reduc
respect
fact
cf
sputum
diffus
barrier
support
observ
remov
dilut
cf
sputum
wash
phosphat
buffer
salin
pb
addit
lipoplex
restor
gene
transfer
capac
lipoplex
furthermor
incub
cell
dna
solut
contain
genom
dna
remov
dna
solut
lipoplex
mediat
transfect
still
caus
decreas
gene
transfer
addit
capac
lipoplex
adenovir
vector
transfect
cell
expos
cf
sputum
dna
solut
respect
partli
complet
restor
cell
incub
rhdnase
transfect
consequ
observ
indic
dna
present
cf
sputum
strongli
bind
epitheli
cell
surfac
cell
associ
dna
drastic
limit
gene
transfer
lipoplex
adenovir
vector
rhdnase
increas
gene
transfer
cell
expos
cf
sputum
remov
dna
becam
bound
cell
surfac
later
group
alton
et
al
also
evalu
effect
undilut
cf
sputum
transfect
effici
nan
studi
sheep
trachea
cover
mm
thick
layer
cf
sputum
abil
base
lipoplex
adenovir
vector
transfect
underli
epithelium
determin
compar
transfect
effici
absenc
cf
sputum
effici
nan
significantli
decreas
cf
sputum
surprisingli
adenovir
vector
much
affect
cf
sputum
layer
lipoplex
presenc
cf
sputum
gene
transfer
lipoplex
adenovirus
respect
lower
fig
b
ex
vivo
sheep
trachea
model
also
use
evalu
effect
normal
sheep
respiratori
mucu
gene
transfer
capac
lipoplex
polyplex
sendai
adenovir
vector
interestingli
experi
demonstr
normal
respiratori
mucu
repres
barrier
adenoviru
sendai
mediat
gene
transfer
gene
transfer
lipoplex
polyplex
lower
presenc
normal
respiratori
mucu
fig
hypothes
result
relat
differ
surfac
charg
nonvir
viral
nan
inde
lipoplex
polyplex
posit
charg
henc
prone
electrostat
bind
mucin
neg
charg
viral
vector
adenovirus
sendai
virus
seem
possess
natur
strategi
overcom
normal
respiratori
mucu
surpris
adenovirus
caus
common
cold
hydrophob
interact
play
role
format
mucin
gel
therefor
possibl
virus
like
adenovirus
hydrophob
moieti
surfac
disrupt
hydrophob
cross
link
mucin
howev
report
transmembran
mucin
strongli
imped
adenovir
gene
transfer
final
want
remark
cf
patient
amount
inhal
nan
come
contact
cm
cf
sputum
much
lower
amount
nan
use
vitro
alton
group
sander
et
al
therefor
one
realiz
chanc
nan
overcom
cf
sputum
barrier
vivo
like
highli
underestim
vitro
experi
also
vivo
experi
mice
inde
latter
experi
ratio
administ
pdna
dose
lung
surfac
much
higher
achiev
cf
patient
upon
topic
deliveri
nan
lung
peripheri
encount
lipid
pulmonari
surfact
layer
first
endogen
interfac
alveolar
region
therefor
influenc
pulmonari
surfact
lipid
particl
characterist
transfect
effici
intens
investig
gener
find
studi
presenc
synthet
especi
natur
deriv
surfact
prepar
result
dosedepend
transfect
inhibit
cation
lipid
base
nan
contrast
natur
deriv
surfact
prepar
commonli
use
product
alveofact
synthet
surfact
prepar
eg
exosurf
contain
surfact
protein
anion
lipid
report
especi
neg
charg
lipid
inhibit
gene
transfer
mediat
cation
lipoplex
suggest
inhibitori
effect
result
disintegr
lipoplex
neg
charg
lipid
lead
access
pdna
nucleas
thu
degrad
loss
function
therefor
pulmonari
surfact
repres
critic
barrier
lead
fatal
interact
lipoplex
interestingli
nan
deriv
cation
polym
polyethylenimin
pei
dendrim
pamam
demonstr
resist
detriment
effect
pulmonari
surfact
neither
peipdna
pamampdna
complex
inhibit
natur
deriv
synthet
surfact
prepar
vitro
vivo
howev
isol
neg
charg
lipid
pulmonari
surfact
result
compar
transfect
inhibit
observ
lipoplex
therefor
suggest
inhibitori
effect
compens
constitu
natur
deriv
surfact
presum
surfact
protein
although
requir
detail
investig
clear
advantag
nan
deriv
cation
polym
seem
increas
complex
stabil
avoid
complex
disintegr
surfact
lipid
synthet
surfact
exosurf
report
even
increas
transfect
effici
pamampdna
complex
result
illustr
nan
deriv
cation
polym
subject
fatal
interact
pulmonari
surfact
lipid
may
therefor
suitabl
gene
deliveri
alveolar
epithelium
vivo
howev
commerci
avail
lung
surfact
prepar
complet
repres
liquid
layer
present
alveoli
therefor
roseneck
et
al
studi
via
electrophoresi
interact
nan
protein
fraction
present
human
balf
balf
protein
absorb
intens
lipoplex
polyplex
addit
glycosyl
compon
balf
strongli
bound
lipoplex
weakli
polyplex
interact
result
increas
lipoplex
diamet
slight
decreas
surfac
charg
size
polyplex
affect
surfac
charg
chang
posit
neg
case
interact
balf
lead
nan
disintegr
assess
quench
assay
reflect
true
bind
balf
compon
nan
surfac
interestingli
transfect
inhibit
stronger
polyplex
lipoplex
although
latter
prone
adsorpt
balf
compon
possibl
reason
first
view
oppos
observ
could
loss
posit
charg
polyplex
surfac
suggest
precondit
initi
bind
neg
charg
cell
surfac
subsequ
cellular
uptak
summari
observ
demonstr
lipid
protein
present
balf
interact
nan
respons
transfect
inhibit
although
lipoplex
gener
suscept
interact
balf
compon
polyplex
transfect
effici
remain
contrast
polyplex
rel
unaffect
presenc
balf
overcom
mucu
alveolar
fluid
layer
pulmonari
gene
therapi
increas
mobil
nan
respiratori
mucu
facilit
mobil
protect
mucu
layer
certain
bacteria
fungi
virus
secret
enzym
hydrolyz
mucin
therefor
mani
research
group
evalu
effect
differ
mucolyt
agent
either
degrad
actin
dna
mucin
mobil
nan
nanospher
cf
mucu
howev
discuss
mucolyt
agent
degrad
biopolym
build
threedimension
polym
network
cf
sputum
increas
mesh
size
also
viscou
drag
mesh
crosslink
biopolym
therefor
expect
effect
mucolyt
agent
transport
nan
nanoparticl
especi
cf
sputum
limit
howev
exclud
mucolyt
posit
effect
transport
nan
nanospher
normal
respiratori
mucu
biophys
properti
cf
sputum
overview
report
effect
differ
mucolyt
transport
nanospher
gene
transfer
effici
nan
given
recombin
human
dnase
rhdnase
clinic
use
enzym
liquefi
cf
mucu
cleav
dna
chain
cf
mucu
rhdnase
administ
cf
patient
via
inhal
effect
rhdnase
mobil
nanoparticl
cf
sputum
studi
three
report
show
transport
nm
polystyren
nanospher
dotapdop
base
lipoplex
respect
higher
sputa
liquefi
rhdnase
rhdnaseml
via
mpt
dawson
et
al
show
averag
mobil
nm
polystyren
nanospher
alter
cf
sputum
liquefi
rhdnase
howev
rhdnase
decreas
spread
diffus
coeffici
nanoparticl
final
group
shute
et
al
also
found
effect
rhdnase
transport
nanospher
synthet
cf
sputum
ie
mixtur
dna
mucin
actin
howev
addit
experi
demonstr
lack
effect
rhdnase
transport
nanospher
due
inhibit
rhdnase
actin
inde
magnesium
concentr
synthet
sputum
mm
low
keep
actin
fulli
polymer
therefor
signific
amount
actin
monom
strongli
inhibit
rhdnase
expect
present
synthet
sputum
propos
gelsolin
also
besid
depolymer
actin
dissoci
dnaseactin
complex
howev
simultan
addit
gelsolin
rhdnase
restor
rhdnase
activ
increas
transport
nanospher
synthet
sputum
nacetylcystein
nac
deriv
lower
viscos
elast
mucu
reduc
disulfid
bond
subunit
mucin
mucin
degrad
agent
administ
oral
via
inhal
clinic
use
eg
asthma
copd
cf
patient
enhanc
clearanc
respiratori
secret
interestingli
report
nacystelyn
lysin
salt
nac
inhibit
matur
dendrit
cell
possess
antiinflammatori
properti
properti
nacystelyn
may
reduc
immun
respons
especi
viral
nan
effect
nacetylcystein
base
mucolyt
efficaci
nan
transport
nanospher
mucu
exclus
evalu
normal
respiratori
mucu
probabl
due
limit
effect
mucolyt
agent
viscos
elast
cf
sputum
use
ex
vivo
sheep
trachea
model
ferrari
et
al
demonstr
gene
transfer
ethyldimyristoylphosphatidyl
cholinecholesterol
edmpcchol
base
lipoplex
linear
pei
base
polyplex
higher
mucu
cover
epithelium
treat
nacystelyn
nac
applic
nan
interestingli
intranas
administr
nacystelyn
mm
min
intranas
applic
edmpcchol
base
lipoplex
result
increas
gene
express
nasal
turbin
mice
strikingli
nasal
deliveri
nacystelyn
togeth
lipoplex
enhanc
even
slightli
decreas
gene
transfer
effici
lipoplex
also
kushwah
et
al
found
intranas
administr
nacystelyn
mm
togeth
diethylaminoethyldextran
deaedextran
coat
adenovirus
enhanc
gene
transfer
effici
lung
mice
howev
intranas
administr
nacystelyn
min
applic
deaedextran
coat
adenovirus
significantli
increas
distribut
level
gene
express
lung
mice
therefor
benefit
mucolyt
gene
transfer
nan
probabl
compens
enhanc
clearanc
nan
respiratori
tract
nan
mucolyt
agent
administ
togeth
airway
importantli
nacystelyn
pretreat
enhanc
gene
transfer
uncoat
adenovirus
lung
mice
line
observ
normal
respiratori
mucu
repres
barrier
neg
charg
adenovir
vector
ex
vivo
sheep
trachea
model
group
alton
et
al
final
nacystelyn
also
increas
transport
neg
charg
polystyren
nanospher
nm
synthet
cf
sputum
magnetofect
novel
method
enhanc
effici
nan
approach
nan
associ
magnet
particl
magnet
forc
use
pull
magnet
nan
toward
target
cell
possibl
also
insid
target
cell
magnetofect
shown
increas
transfect
effici
nan
cell
cultur
vivo
furthermor
dame
et
al
demonstr
aerosol
droplet
compris
superparamagnet
nanoparticl
spion
call
nanomagnetosol
could
effici
target
desir
region
lung
mice
applic
extern
magnet
gradient
field
inhal
import
progress
toward
deposit
higher
dosag
nan
desir
lung
region
specul
magnet
gradient
field
may
also
pull
magnet
nan
mucu
alveolar
fluid
barrier
addit
usag
puls
magnet
field
addit
target
magnet
field
may
facilit
uptak
magnet
nan
respiratori
cell
addit
mucolyt
agent
mucu
mainli
result
reduct
macroviscos
howev
discuss
earlier
mobil
small
nanospher
nm
cf
sputum
determin
microviscos
ie
viscos
mesh
network
macroviscos
therefor
enhanc
mobil
nanoparticl
cf
sputum
mucolyt
agent
specif
lower
microviscos
degrad
polym
present
mesh
latter
reduc
viscou
drag
diffus
nanoparticl
encount
without
releas
extra
polym
threedimension
network
mesh
hand
larger
nanoparticl
often
cage
mesh
even
enter
mesh
present
mucu
gel
larger
nm
nanoparticl
mucolyt
agent
first
place
cut
filament
build
threedimension
network
therefor
take
account
consider
give
nan
capac
specif
cleav
biopolym
encount
way
mucu
done
link
mucolyt
enzym
surfac
nan
nanoparticl
gener
enzym
degrad
mucin
dna
actin
collagen
protein
filament
interest
candid
function
nan
expect
cut
way
mucu
observ
linkag
collagenas
nanoparticl
enhanc
transport
extracellular
matrix
prove
idea
may
inde
work
final
also
give
extra
speed
nan
attach
motor
surfac
propos
strategi
may
sound
quit
futurist
howev
autonom
movement
nanos
object
obtain
put
chemic
nanomotor
surfac
lowfrequ
khz
ultrasound
use
enhanc
transport
drug
drug
carrier
skin
via
mechan
describ
sonophoresi
sonophoresi
mainli
caus
acoust
cavit
ie
format
oscil
collaps
gaseou
microbubbl
fluid
expos
ultrasound
wave
bubbl
spontan
form
ultrasound
dissolv
air
present
fluid
cavit
either
stabl
inerti
stabl
cavit
correspond
period
growth
shrink
microbubbl
inerti
cavit
defin
violent
growth
collaps
microbubbl
due
collaps
bubbl
shock
wave
microjet
gener
effect
may
increas
veloc
nan
mesh
size
mucu
recent
studi
observ
transport
polystyren
nanospher
nm
neg
charg
cf
sputum
higher
presenc
lowfrequ
ultrasound
sander
et
al
unpublish
data
experi
use
vertic
diffus
chamber
setup
fig
expos
cf
sputum
discontinu
prevent
heat
ultrasound
take
account
use
puls
ultrasound
total
exposur
time
ultrasound
durat
transport
experi
therefor
applic
ultrasound
longer
period
probabl
caus
drastic
increas
although
data
promis
want
remark
applic
ultrasound
lung
simpl
inde
ultrasound
enter
lung
sourc
outsid
bodi
highli
reflect
air
lung
therefor
prevent
reflect
ultrasound
air
lung
one
may
also
directli
insert
ultrasound
probe
lung
via
bronchoscop
done
bronchoscop
ultrasound
examin
tracheobronchi
tree
highfrequ
ultrasound
togeth
diagnost
microbubbl
increas
gene
transfer
efficaci
nake
pdna
nan
temporarili
perfor
cell
membran
xenari
et
al
recent
found
extern
highfrequ
ultrasound
sourc
mhz
combin
diagnost
microbubbl
increas
gene
transfer
nake
pdna
lung
mice
data
may
indic
highfrequ
ultrasound
reach
lung
epitheli
cell
mice
know
whether
highfrequ
ultrasound
also
increas
transport
nan
mucu
one
success
strategi
avoid
interact
nan
compon
biolog
fluid
modif
biocompat
hydrophil
biolog
inert
polym
obviou
concept
may
applic
pulmonari
gene
deliveri
reduct
interact
mucu
alveolar
fluid
compon
highli
desir
shield
nan
may
import
reduc
interact
mucu
alveolar
fluid
compon
may
also
diminish
clearanc
alveolar
macrophag
consider
observ
aerosol
deliveri
nonshield
pei
polyplex
section
first
give
overview
differ
strategi
use
avoid
interact
nan
respiratori
secret
subsequ
discuss
behavior
shield
nan
respiratori
cf
secret
close
section
critic
remark
pegyl
although
effect
mucolyt
enzym
interact
nan
mucu
compon
studi
detail
one
expect
degrad
mucu
compon
show
less
fatal
interact
nan
therefor
besid
improv
mobil
nan
cf
mucu
mucolyt
enzym
may
also
decreas
interact
nan
cf
mucu
compon
extracellular
compon
often
interact
nan
via
charg
hydrophob
interact
therefor
aggreg
interact
nan
extracellular
compon
prevent
shield
posit
surfac
charg
nan
neutral
hydrophil
polym
eg
polyethylen
glycol
peg
nan
bear
inert
polym
surfac
obtain
via
two
strategi
first
strategi
use
nonvir
nan
made
via
selfassembl
cation
carrier
coval
coupl
shield
polym
subsequ
mix
nucleic
acid
selfassembl
cation
carrier
nucleic
acid
interact
creat
slightli
hydrophob
core
surround
shield
hydrophil
polym
method
disadvantag
shield
polym
especi
high
amount
shield
polym
use
hinder
selfassembl
process
cation
carrier
nucleic
acid
therefor
postshield
consid
involv
coval
attach
shield
polym
preform
nonvir
nan
howev
pegyl
also
back
draw
inde
well
known
peg
chain
surfac
nan
prevent
endosom
escap
neg
effect
biolog
effici
shield
nan
therefor
differ
group
current
make
nan
lose
pegchain
cell
surfac
acidifi
endosom
final
surfac
charg
nan
also
modifi
absorpt
opposit
charg
polym
exampl
cheung
et
al
coat
cation
nonvir
nan
poli
propylacryl
acid
ppaa
anion
polym
disrupt
endosom
membran
finsing
et
al
coat
cation
surfac
nan
use
peg
link
neg
charg
peptid
drawback
strategi
howev
stabil
ionic
coat
blood
mucu
question
yet
demonstr
postshield
strategi
also
appli
prevent
recognit
viral
nan
immun
system
enabl
retarget
viral
nan
desir
tissu
lipoplex
base
genzym
lipid
lipid
one
success
nan
gene
deliveri
lung
optim
formul
lipoplex
contain
pegyl
lipid
sander
et
al
comprehens
demonstr
benefit
presenc
peglipid
lipoplex
contrast
cation
dotapdop
lipoplex
exposur
pegyl
lipoplex
cf
mucu
compound
linear
dna
albumin
phospholipid
mucin
concentr
expect
occur
vivo
affect
gene
transfect
activ
addit
peg
chain
prevent
lipoplex
becam
aggreg
cf
mucu
compound
similar
observ
made
peg
copolymerprotect
pei
polyplex
adsorb
low
amount
serumderiv
protein
virtual
inert
mucin
bind
balf
howev
copolym
protect
result
strong
decreas
transfect
effici
mous
lung
could
partial
restor
coupl
transferrin
target
ligand
increas
colloid
stabil
presenc
balf
also
observ
pegyl
tat
peptidemodifi
pei
polyplex
anoth
approach
success
perform
achiev
high
transfect
effici
pei
polyplex
presenc
cf
sputum
sol
phase
make
use
polyplex
preincub
serum
albumin
although
underli
mechan
entir
elucid
till
preincub
pei
polyplex
human
serum
albumin
result
higher
transfect
rate
presenc
cf
sputum
without
human
serum
albumin
author
specul
albuminco
pei
polyplex
may
target
albumin
receptor
express
apic
surfac
context
observ
coupl
target
ligand
nan
may
repres
suitabl
approach
augment
transfect
effici
increas
gene
transfer
effici
obtain
lung
epitheli
cell
variou
target
ligand
like
spb
utp
mannuron
acid
lactoferrin
coupl
target
ligand
nan
may
particular
interest
increas
intern
kinet
target
lung
cell
term
fast
clearanc
kinet
alveolar
macrophag
inde
one
consid
one
microlit
mm
balf
contain
roughli
alveolar
macrophag
summari
result
allow
us
conclud
shield
nan
eg
polyethylen
glycol
favor
physicochem
stabil
gene
transfer
capac
presenc
respiratori
cf
secret
presenc
eg
peg
polym
surfac
nan
prevent
aggreg
avoid
nan
come
close
proxim
collis
howev
surfac
nan
often
complet
cover
shield
polym
therefor
shield
polym
gap
may
present
allow
small
charg
molecul
reach
surfac
nan
inde
exampl
observ
albumin
concentr
found
blood
abl
penetr
peg
sirnaliposom
complex
contain
mol
peglipid
caus
releas
sirna
similarli
high
amount
albumin
could
releas
one
third
pdna
pegyl
lipoplex
indic
albumin
one
hand
small
enough
penetr
peg
chain
hand
larg
enough
allow
thermodynam
competit
pdna
bind
cation
lipid
anion
phospholipid
present
lung
surfact
also
abl
dissoci
pegyl
lipoplex
howev
dissoci
limit
occur
lipoplex
incub
extrem
high
concentr
lung
surfact
indic
thermodynam
power
neg
charg
phospholipid
push
much
larger
pdna
molecul
cation
liposom
low
prevent
small
molecul
like
albumin
penetr
pegchain
pegyl
nan
one
either
increas
degre
shield
chain
length
polym
howev
one
realiz
exampl
long
peg
chain
n
kda
may
entangl
biopolym
network
biogel
therefor
particl
contain
long
peg
chain
may
becom
immobil
mucu
design
new
nan
respiratori
gene
therapi
one
take
account
respiratori
secret
present
target
cell
review
demonstr
size
surfac
properti
especi
nonvir
nan
determin
behavior
respiratori
secret
first
key
messag
cation
surfac
nonvir
nan
shield
neutral
hydrophil
polym
prevent
nan
stick
threedimension
polym
network
respiratori
mucu
andor
becom
cover
dissoci
macromolecul
embed
mucu
network
addit
nan
hydrophob
surfac
also
expect
stick
mucu
network
size
nan
matter
two
independ
report
clearli
found
smaller
nanoparticl
less
retard
cf
sputum
base
report
conclud
nan
nm
smaller
allow
free
passiv
mesh
network
cf
sputum
howev
one
realiz
size
necessarili
optim
size
free
diffus
nan
normal
respiratori
mucu
type
mucu
inde
recent
demonstr
larg
surfac
shield
polystyren
nanospher
move
faster
cervic
mucu
smaller
also
surfac
shield
counterpart
import
realiz
thick
mucu
layer
also
import
barrier
inde
small
fraction
nanoparticl
cross
thick
mucu
blanket
within
min
ie
estim
renew
time
respiratori
mucu
therefor
drastic
enhanc
number
nan
reach
cell
beneath
mucu
layer
one
give
motil
nan
possibl
approach
exampl
attach
nanomotor
nan
use
ultrasound
magnet
forc
besid
optim
design
nan
one
also
tri
reduc
barrier
properti
respiratori
secret
data
literatur
consist
confirm
treatment
respiratori
tract
mucolyt
agent
like
nac
rhdnase
least
min
administr
nan
significantli
favor
respiratori
gene
transfer
via
pretreat
mucolyt
signific
amount
mucu
probabl
remov
